Clinical Utility of Midregional Proadrenomedullin in Patients with COVID-19.

Bruna Lo SassoCaterina Maria GambinoNicola ScichiloneRosaria Vincenza GiglioGiulia BivonaConcetta ScazzoneRoberto MuratoreSalvatore MilanoMario BarbagalloLuisa AgnelloMarcello Ciaccio

Published in: Laboratory medicine (2021)

We found that MR-proADM could represent a prognostic biomarker of COVID-19.

Keyphrases

coronavirus disease
sars cov
contrast enhanced
magnetic resonance
respiratory syndrome coronavirus
magnetic resonance imaging
computed tomography